Cargando…

Investigational Approaches for Mesothelioma

Malignant pleural mesothelioma (MPM) is a rare, aggressive tumor with a poor prognosis. In view of the poor survival benefit from first-line chemotherapy and the lack of subsequent effective treatment options, there is a strong need for the development of more effective treatment approaches for pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surmont, Veerle F., van Thiel, Eric R. E., Vermaelen, Karim, van Meerbeeck, Jan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364459/ https://www.ncbi.nlm.nih.gov/pubmed/22666659 http://dx.doi.org/10.3389/fonc.2011.00022

Ejemplares similares

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017)

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report
por: Van Acker, Lander, et al.
Publicado: (2021)

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
por: Janssens, Eline, et al.
Publicado: (2022)

Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
por: Janssens, Eline, et al.
Publicado: (2022)

Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot Study
por: Salhi, B., et al.
Publicado: (2010)

Surgical series in mesothelioma: navigating between biases
por: Raskin, Jo, et al.
Publicado: (2023)

Mesothelioma treatment: Are we on target? A review
por: Hiddinga, Birgitta I., et al.
Publicado: (2015)

Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
por: Schillebeeckx, Eline, et al.
Publicado: (2021)

Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression
por: Marcq, Elly, et al.
Publicado: (2019)

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma
por: Raman, Lennart, et al.
Publicado: (2020)

Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome
por: Van der Linden, Malaïka, et al.
Publicado: (2022)

Optimal approach for upfront resectable non-small-cell lung cancer
por: van Meerbeeck, Jan P.
Publicado: (2013)

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
por: Rovers, Sophie, et al.
Publicado: (2022)

Invasive Aspergillosis Mimicking Metastatic Lung Cancer
por: Vanfleteren, Michiel J. E. G. W., et al.
Publicado: (2018)

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.
por: van Meerbeeck, J., et al.
Publicado: (1996)

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3
por: Marcq, Elly, et al.
Publicado: (2021)

Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma
por: Hylebos, Marieke, et al.
Publicado: (2017)

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
por: van Haarst, J M W, et al.
Publicado: (2002)

Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study
por: Lamote, Kevin, et al.
Publicado: (2017)

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
por: Marcq, Elly, et al.
Publicado: (2017)

Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review
por: Van Der Weijst, Lotte, et al.
Publicado: (2019)

Neurocognitive functioning following lung cancer treatment: The PRO-Long Study
por: van der Weijst, Lotte, et al.
Publicado: (2022)

Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study
por: Van Der Weijst, Lotte, et al.
Publicado: (2021)

A Feasibility Study to Investigate Chemogenetic Modulation of the Locus Coeruleus by Means of Single Unit Activity
por: Stevens, Latoya, et al.
Publicado: (2020)

Supplementary Prognostic Variables for Pleural Mesothelioma: A Report from the IASLC Staging Committee
por: Pass, Harvey I., et al.
Publicado: (2014)

Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
por: Vermaelen, Karim
Publicado: (2019)

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
por: Van Assche, Katrijn, et al.
Publicado: (2014)

Approaches and Limitations in the Investigation of Synaptic Transmission and Plasticity
por: Glasgow, Stephen D., et al.
Publicado: (2019)

Novel teatment options in early-stage non-small-cell lung cancer
por: van Meerbeeck, Jan P.
Publicado: (2013)

Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
por: Dipper, Alex, et al.
Publicado: (2021)

Multivariate analytical approaches for investigating brain-behavior relationships
por: Durham, E. Leighton, et al.
Publicado: (2023)

The seventh tumour–node–metastasis staging system for lung cancer: Sequel or prequel?
por: van Meerbeeck, Jan P., et al.
Publicado: (2013)

Lung cancer screening in Europe: where are we in 2021?
por: van Meerbeeck, Jan P., et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

BTS guideline for the investigation and management of malignant pleural mesothelioma
por: Woolhouse, Ian, et al.
Publicado: (2018)

The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
por: Oguh-Olayinka, Lily, et al.
Publicado: (2019)

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
por: Bibby, Anna C., et al.
Publicado: (2016)

Semi-intact ex vivo approach to investigate spinal somatosensory circuits
por: Hachisuka, Junichi, et al.
Publicado: (2016)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d2ot8auuh2gip8649e5pma434s